CMES7 Hypophosphatasia: New Options in the Management of Alkaline Phosphatase Deficiency

Program: CMES Ancillary Events
Clinical Session
Sunday, April 3, 2016: 5:45 AM-8:00 AM
Grand Ballroom (The Westin)
Supported by an educational grant from Alexion Pharmaceuticals, Inc.

Registration is required for this session:

Learning Objectives:

Upon completion of this educational activity, learners will be better able to:

  • Describe the role of alkaline phosphatase and discuss the genetic underpinnings of hypophosphatasia
  • Evaluate clinical presentation, biochemical tests, and radiological images in the diagnosis of hypophosphatasia
  • Integrate supportive therapy to minimize disease-related systemic sequelae in the management of hypophosphatasia
  • Apply recently approved treatment option in perinatal, infantile and juvenile-onset hypophosphatasia
6:00 AM

Jill H Simmons, MD, Division of Endocrinology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN
Disclosures:
JHS: Advisory Group Member, Alexion.
6:05 AM

Nancy S Dunbar, MD, MPH, Connecticut Children's Medical Center, Hartford, CT
Disclosure Not Provided: NSD
6:30 AM

Peter J Tebben, MD, Department of Pediatric and Adolescent Medicine, Division of Endocrinology, Mayo Clinic, Rochester, MN
Nothing to Disclose: PJT
6:55 AM

Michael P Whyte, MD, Shriners Hospitals for Children, St. Louis, MO
Disclosure Not Provided: MPW
7:25 AM

Jill H Simmons, MD, Division of Endocrinology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN
Disclosures:
JHS: Advisory Group Member, Alexion.
See more of: CMES Ancillary Events